GLP-1 receptor agonists have revolutionized the treatment of obesity and type 2 diabetes. As demand for these medications continues to outpace commercial supply, compounded Semaglutide has emerged as a viable option for physicians seeking to provide patient access to this important class of medications.
Compounded Semaglutide is prepared from pharmaceutical-grade Semaglutide sodium salt in USP 795-compliant compounding facilities. When sourced from reputable community pharmacies that employ rigorous quality testing, compounded formulations can provide consistent, reliable results.
Key quality indicators physicians should look for include: Certificate of Analysis for every batch, HPLC purity testing confirming identity and concentration, sterility and endotoxin testing results, proper beyond-use dating, and temperature-controlled shipping protocols.
At Nuvexa Pharmaceuticals, our GLP-1 compounds undergo dual-layer quality testing — initial in-house analysis followed by independent third-party verification. This approach ensures every vial meets our exacting standards.
Nuvexa Clinical Team
PharmD
Clinical pharmacist at Nuvexa Pharmaceuticals specializing in compounded pharmaceutical preparations and quality assurance.